Japan
GC Biopharma and Novel Pharma Dose First US Patient in Pioneering Clinical Trial for Sanfilippo Syndrome Type A
GC Biopharma and Novel Pharma announced that the first patient in the US has been dosed in multinational clinical trial with 'GC1130A', an innovative new d...
November 26, 2024 | News
NTT and Olympus Showcase Breakthrough in Cloud-Based Endoscopy with IOWN APN Technology
NTT Corporation (TSE: 9432; “NTT”) and Olympus Corporation (TSE: 7733; “Olympus”) have successfully demonstrated the world’s ...
November 22, 2024 | News
Eisai Launches Rozebalamin® in Japan, Offering New Hope for ALS Patients
Eisai Co., Ltd. announced that the amyotrophic lateral sclerosis (ALS) treatment “Rozebalamin® for Injection25 mg” (mecobalamin) has ...
November 21, 2024 | News
Kura Oncology and Kyowa Kirin Forge $1.5 Billion Global Partnership for Ziftomenib in AML Across U.S., Japan, and International Markets
Kura to receive a $330 million upfront payment and up to $1.2 billion in total milestone payments, including $420 million in ...
November 21, 2024 | News
Singleron Biotechnologies Partners with TOMY Digital Biology to Expand Single Cell Analysis Solutions in Japan
Singleron Biotechnologies, a leader in single cell analysis solutions, has announced a new distributor partnership with TOMY Digital Biology Co., Ltd. Unde...
November 20, 2024 | News
Nxera Pharma Secures $3.5M Milestone as Centessa Pharmaceuticals Launches Phase 2 Trial of ORX750 for Sleep Disorders
Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) – formerly known as Sosei Group or Sosei Heptares – notes t...
November 14, 2024 | News
Japan’s GHIT Fund Invests JPY 578 Million to Advance Diagnostics and Treatments for Neglected Tropical Diseases and Malaria
The Global Health Innovative Technology (GHIT) Fund has announced a total investment of approximately JPY 578 million (USD 4.0 million) in four projects ai...
November 07, 2024 | News
Inocras and Summit Pharmaceuticals Ink MOU to Transform Genomic Medicine in Japan
Inocras Inc. and Summit Pharmaceuticals International Corporation (“SPI”) signed an MOU (Memorandum of understanding) to jointly ex...
November 06, 2024 | News
Thermo Fisher Concludes Successful Bioprocess World Tour 2024 in APJ, Reigniting Industry Momentum Post-COVID
Thermo Fisher Scientific is proud to announce the successful conclusion of its highly anticipated Bioprocess World Tour 2024 in the Asia-Pacific and Japan ...
October 23, 2024 | News
Asahi Kasei Medical Launches Planova™ FG1: A Next-Generation Virus Removal Filter for Enhanced Biopharmaceutical Manufacturing
Asahi Kasei Medical, a global leader in virus removal solutions, proudly announces the launch of the Planova™ FG1, a next-generation virus removal fi...
October 23, 2024 | News
SONIRE Therapeutics Secures FDA Breakthrough Device Designation for Advanced HIFU Therapy in Pancreatic Cancer
SONIRE Therapeutics Inc. (hereinafter referred to as "SONIRE"), based in Tokyo, Japan, announces that its self-developed next-generation HIFU (Hi...
October 17, 2024 | News
Astellas Secures Exclusive Option for AVB-101 Gene Therapy in $2.18 Billion Deal with AviadoBio
Astellas receives an exclusive option to license AVB-101, an investigational, AAV-based gene therapy in Phase 1/2 development Av...
October 11, 2024 | News
Ciconia Bioventures Launched as Joint Venture to Drive Global Drug Discovery from Japan
Ciconia Bioventures Inc. (Representative Director, Founder CEO: Toshio Fujimoto, "Ciconia") announced its establishment as a joint venture compan...
October 09, 2024 | News
Evonik Launches Global Competence Network to Advance Cell Culture-Based Therapies
First point of contact for partners seeking to manufacture cell culture-based therapies more efficiently Draws on multidisciplinary team of experts Dri...
October 03, 2024 | News
Most Read
- Why Cell Therapy Systems Are Going Automatic: A New Era of Manufacturing
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2025
- 2025 Pharma and Medical Device Trends for Manufacturing Leaders
- 25 High-Value Drugs Losing Patent Protection in 2025: What It Means for Healthcare
- BioPharma Trends 2025: 25 Key Insights Shaping Asia Pacific's Future
- Driving Oncology Forward: 25 Companies Redefining Antibody-Drug Conjugates (ADCs) in 2025
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Top Management Shakeups of 2024: Redefining Pharma, Biopharma, and Biotech Leadership
- James Park Joins South Korean LOTTE BIOLOGICS as New CEO to Lead Global Expansion
- Australia Takes the Lead: Moderna Opens Southern Hemisphere’s First mRNA Manufacturing Facility in Victoria
- Eli Lilly Announces $3 Billion Expansion in Wisconsin to Boost Global Medicine Production
- Ngee Ann Polytechnic Partners with Merck Singapore to Elevate Biopharmaceutical Education
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Life Sciences CEOs Bet Big on AI and Workforce Growth Despite Economic and Industry Headwinds
News
